These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21145422)

  • 1. Barrett's esophagus progressing to cancer: a needle in a haystack?
    Lewis JJ; Rubenstein JH
    Clin Gastroenterol Hepatol; 2011 Mar; 9(3):194-5. PubMed ID: 21145422
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer incidence in Barrett's esophagus: does it really matter, and who's counting anyway?
    Corley DA
    Gastrointest Endosc; 2008 Mar; 67(3):399-401. PubMed ID: 18294502
    [No Abstract]   [Full Text] [Related]  

  • 3. The incidence of esophageal adenocarcinoma among patients with nondysplastic Barrett's esophagus has been overestimated.
    Desai TK; Samala N
    Clin Gastroenterol Hepatol; 2011 Apr; 9(4):363-4; author reply 364-5. PubMed ID: 21115135
    [No Abstract]   [Full Text] [Related]  

  • 4. Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study.
    Bytzer P; Christensen PB; Damkier P; Vinding K; Seersholm N
    Am J Gastroenterol; 1999 Jan; 94(1):86-91. PubMed ID: 9934736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenocarcinoma and Barrett's esophagus. An overrated risk?
    Spechler SJ; Robbins AH; Rubins HB; Vincent ME; Heeren T; Doos WG; Colton T; Schimmel EM
    Gastroenterology; 1984 Oct; 87(4):927-33. PubMed ID: 6468881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barrett's esophagus: does the incidence of adenocarcinoma matter?
    Cameron AJ
    Am J Gastroenterol; 1997 Feb; 92(2):193-4. PubMed ID: 9040189
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening for Barrett's esophagus.
    Spechler SJ
    Rev Gastroenterol Disord; 2002; 2 Suppl 2():S25-9. PubMed ID: 12478241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years.
    Drewitz DJ; Sampliner RE; Garewal HS
    Am J Gastroenterol; 1997 Feb; 92(2):212-5. PubMed ID: 9040193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barrett's esophagus and cancer. Preface.
    Sharma P
    Surg Oncol Clin N Am; 2009 Jul; 18(3):xv-xvi. PubMed ID: 19500731
    [No Abstract]   [Full Text] [Related]  

  • 10. Barrett's esophagus and risk of esophageal adenocarcinoma.
    Cossentino MJ; Wong RK
    Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Another strike against esophagectomy for high-grade dysplasia in Barrett's esophagus?
    Wani S; Sharma P
    Clin Gastroenterol Hepatol; 2008 Feb; 6(2):128-9. PubMed ID: 18237863
    [No Abstract]   [Full Text] [Related]  

  • 12. Is the incidence of esophageal adenocarcinomas in patients with Barrett's esophagus really overestimated?
    Younes M
    Gastroenterology; 2005 Dec; 129(6):2125-6; author reply 2126. PubMed ID: 16344087
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of Barrett's esophagus: cases and questions.
    Bresalier R
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S2-5. PubMed ID: 16399421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shining light on Barrett's esophagus.
    Quaroni L; Zhao R; Casson AG
    Expert Rev Gastroenterol Hepatol; 2009 Dec; 3(6):577-80. PubMed ID: 19929578
    [No Abstract]   [Full Text] [Related]  

  • 15. Epidemiology of Barrett's esophagus.
    Cameron AJ
    Gastroenterol Clin Biol; 1994; 18(1 Pt 2):D3-4. PubMed ID: 8013779
    [No Abstract]   [Full Text] [Related]  

  • 16. [Adenocarcinoma in Barrett's esophagus. A retrospective study of 46 patients followed during 3.5 years].
    Bujanda Fernández de Piérola L; Muñoz Villafranca C; Sánchez Martínez A; Iriondo Martínez de Luco C; Aras Portilla LM
    An Med Interna; 1999 Apr; 16(4):178-80. PubMed ID: 10339842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for esophageal cancer development.
    Falk GW
    Surg Oncol Clin N Am; 2009 Jul; 18(3):469-85. PubMed ID: 19500737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etiology of Barrett's metaplasia and esophageal adenocarcinoma.
    Kim R; Weissfeld JL; Reynolds JC; Kuller LH
    Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):369-77. PubMed ID: 9149898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry.
    O'Connor JB; Falk GW; Richter JE
    Am J Gastroenterol; 1999 Aug; 94(8):2037-42. PubMed ID: 10445525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence of esophageal adenocarcinoma in Barrett's esophagus has been overestimated.
    Desai TK; Singh J; Samala N; Subbiah P
    Am J Gastroenterol; 2011 Jul; 106(7):1364-5; author reply 1365-6. PubMed ID: 21731021
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.